Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma

NCT00278421 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

592

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: rituximab
DRUG: cyclophosphamide
DRUG: doxorubicin hydrochloride
DRUG: prednisone
DRUG: vincristine sulfate

Sponsor

German High-Grade Non-Hodgkin's Lymphoma Study Group